A Guide to Dossier Preparation for Indonesia Medical Device Registration

Securing market access for a medical device or In Vitro Diagnostic (IVD) product in Indonesia requires a structured approach to technical documentation. Manufacturers must prepare a complete registration dossier demonstrating that their device complies with Indonesian regulatory requirements for safety, quality and performance before it can be legally imported or marketed.

For overseas manufacturers, specific and avoidable errors — such as mismatched product names across files, expired certificates, un-legalized documents, or incorrect risk classifications — frequently halt the review process and delay market access.

This guide outlines the administrative and technical documents required for medical device and IVD registration in Indonesia. For personalized regulatory strategy, gap analysis, or direct submission support in Indonesia, contact Cisema today.

Indonesia's Medical Device Regulatory Framework

Before you compile a single technical document, it is important to first understand the legal rules that govern who can submit an application and how products are controlled in Indonesia.

Indonesia regulates medical devices under a framework aligned with the ASEAN Medical Device Directive (AMDD). The MoH manages the entire lifecycle of an application electronically through the Regalkes platform, which is integrated into the nation’s Online Single Submission Risk-Based Approach (OSS RBA) system.

However, the most critical legal rule for foreign manufacturers to understand is the Single-Distributor Principle.

The Single-Distributor Principle (MoH Regulation No. 62 of 2017)

A medical device can only be registered under one local license holder at a time. Under Indonesian law, a product marketed under a specific brand or trade name cannot be registered by multiple distributors simultaneously.

Because this local partner will effectively own your product registration (Marketing Authorization) for the Indonesian market, choosing the right entity is your very first, and most strategic, decision.

Pre-Dossier Steps: Appointing Your Partner and Classifying Your Medical Device

With the regulatory framework established, you must complete three foundational steps before compiling your paperwork. The outcomes of these steps dictate the exact technical scope and licensing track of the dossier you will build.

Step 1: Appoint an Indonesian License Holder

Because foreign manufacturers cannot interact directly with the MoH, you must formally appoint a local company to act as your Marketing Authorization Holder (MAH). This relationship is formalized through a legal Letter of Authorization (LoA). Crucially, your appointed partner must already hold two distinct local licenses:

• A valid Medical Device Distribution License (IDAK)
• A Good Distribution Practice for Medical Devices (CDB) Certificate

Step 2: Confirm the Medical Device Risk Classification

Indonesia applies a risk-based classification system for medical devices and IVDs. The product classification determines the level of technical evidence and supporting documentation expected during review.

*Class A Notification is reserved strictly for specific low-risk, non-sterile, non-IVD medical devices generally intended for home use.

Step 3: Identify Special Track Requirements

Finally, check if your device's technology triggers secondary agency reviews. For instance, wireless devices (Bluetooth/Wi-Fi) require telecom approval from SDPPI, while radiation-emitting equipment requires nuclear licensing from BAPETEN. These external certificates must be secured to complete your dossier.

Part 1 of the Medical Device Dossier: Administrative Documents

With your local partner confirmed and your device classification established, you can begin compiling the actual dossier.

The first part is the Administrative documents, which establish the legal relationship between the manufacturer, the Indonesian License Holder and the registered product.

The MoH reviews these documents to ensure your supply chain is legal, traceable, and authorized.

Letter of Authorization (LoA)

The Letter of Authorization formally appoints the Indonesian License Holder to act on behalf of the overseas manufacturer.

The LoA should:

• Identify both the manufacturer and License Holder
• Clearly specify the authorized products
• Remain valid for the applicable registration period, typically between two and five years
• Be notarized and apostilled or legalized by the Indonesian Embassy where required

An expired or incorrectly prepared LoA may result in application deficiencies.

Certificate of Free Sale (CFS)

The Certificate of Free Sale demonstrates that the product is legally marketed in its country of origin. It should be issued by the Ministry of Health or Health Department in accordance with local country regulations. Where the product is not classified as a medical device in the country of origin, a Chamber of Commerce-issued certificate may be accepted.

The certificate should clearly identify:

• manufacturer name
• product name or model
• product type or model information

Information on the CFS should be consistent with the remainder of the registration dossier.

Quality Management Documentation

Manufacturers are generally expected to provide evidence of an appropriate quality management system.

Typical documentation includes:

• ISO 13485 certificate
• CE certificate, where applicable
• other regulatory approvals where relevant

Certificates should be valid, issued by a Notified Body where applicable, and include the physical manufacturer’s name and address, certification scope, and Notified Body number where relevant.

Additional Administrative Documents

Depending on the product, additional documentation may include:

• Declaration of Conformity
• Brand or Trademark Certificate, where applicable
• Manufacturer declarations
• Supporting legal documents

The Declaration of Conformity should be issued by the manufacturer and include the physical manufacturer’s name, address and the list of applicable standards applied.

All documents should be complete, legible, properly signed and stamped where applicable, and prepared in accordance with Regalkes submission requirements.

Language and Legalization Rules

All documents must be submitted in either Bahasa Indonesia or English. Product labelling and other documentation may require Bahasa Indonesia.

Where required, manufacturers should ensure documents are:

• Professionally or certified translated by qualified Indonesian translators
• Properly signed and stamped
• Notarized, apostilled or legalized where applicable
• Submitted as clear PDF files in accordance with Regalkes electronic submission requirements

Part 2 of the Dossier: Technical Documents

Once the administrative paperwork establishes who is allowed to sell the device, you must compile Part 2: the Technical Documents. This section provides the scientific and clinical proof that the device is safe, effective, and manufactured consistently.

The depth of this section scales directly with your product's risk classification (Class A through D).

Device Description

The dossier should provide sufficient information for regulators to understand the product and its intended use.

Typical documentation includes:

• Executive summary
• Market history
• Manufacturer information, including physical and legal manufacturer name and address
• Device description
• Intended use statement
• Product specifications
• Raw material information
• Model and configuration information
• Brochure
• Product photographs

Labelling Documentation

Labelling documentation should be consistent across the entire submission.

Typical documents include:

• Instructions for Use (IFU) in Bahasa Indonesia and English
• Product labels 
• Packaging artwork 
• User manuals 

Labels should explain the production code, serial number or batch number where applicable. For IVD reagents, packaging specifications should include the material and size of primary, secondary and tertiary packaging where applicable.

Differences between the IFU, labels and technical documentation may result in regulatory queries.

Manufacturing Information

Manufacturers should provide documentation describing how the device is consistently manufactured and controlled.

Supporting information may include:

• Manufacturing process flowcharts 
• Production procedures 
• Quality control processes 
• Packaging information 

Verification and Validation Evidence

The type of evidence required depends on the device.

Supporting documentation may include:

• Electrical safety testing, such as IEC 60601-1, IEC 61010-1 or IEC 62304 where applicable
• EMC reports 
• Software validation
• Biocompatibility reports
• Third-party biocompatibility testing service provider (ISO 17025).
• Sterilization validation reports
• Third-party sterilization service provider certificates, such as ISO 11135, ISO 11137 or ISO 13485, where applicable
• Stability studies
• Accelerated, real-time, in-use/open and transport stability reports for IVD reagents, where applicable
• Sensitivity and specificity reports for IVD reagents
• Raw material MSDS
• Performance testing where applicable

Risk Management and Clinical Evidence

Manufacturers should also provide evidence demonstrating that identified risks have been appropriately managed.

Depending on the product, supporting documentation may include:

• Risk analysis and risk management reports
• Clinical evaluation reports
• QC pass or certificate of analysis for finished products
• Quality control release documentation

Certificates of Analysis should be issued by the manufacturer’s QC function and list the test type, test parameter or standard, test result, and conclusion.

Certain devices may also require additional approvals, such as SDPPI certification for wireless products with Bluetooth, Wi-Fi or radio frequency features, or BAPETEN licensing for radiation-emitting products.

Submission, Review, and Clarification

Once both the administrative and technical components are fully compiled and translated, your dossier is ready for the execution phase.

The submission process follows a structured electronic workflow through the Regalkes portal, managed directly by your local Indonesian License Holder:

1. Reviewing the completeness of the administrative and technical documentation. 
2. Preparing the application for electronic submission through Regalkes. 
3. Ministry of Health review of the submitted dossier. 
4. Responding to any requests for clarification or additional information. 
5. Issuance of the Marketing Authorization (Izin Edar) upon successful review. 

Supporting documents should be uploaded as clear PDF files, with each file generally not exceeding 5 MB.

During Phase 3, if the MoH spots any inconsistencies, the review halts, and a clock begins ticking for you to respond. Submitting a thoroughly vetted dossier from day one is the single best way to avoid these pauses.

For a deep dive into the complete process, read our article: Medical Device Registration in Indonesia: A Practical Guide for Foreign Manufacturers.

Indonesia Medical Device Dossier Checklist 

To ensure your application transitions smoothly through the Regalkes workflow without hitting costly roadblocks, you should conduct a final pre-submission audit.

Review your completed dossier against this checklist and cross-reference your files to eliminate common errors before submission.

Administrative Readiness

1. Has a qualified Indonesian License Holder been appointed?
2. Are all administrative documents, including the Letter of Authorization and Certificate of Free Sale, valid and consistent?
3. Are ISO 13485 certification and any other applicable supporting certificates up to date?
4. Have all required declarations and trademark documents been prepared, where applicable?

Technical Readiness

1. Does the technical dossier clearly describe the device, its intended use, and supporting evidence?
2. Are the Instructions for Use (IFU), product labels, and packaging artwork consistent across all documents?
3. Have all required validation, risk management, and clinical documents been included?
4. Have product-specific approvals or certifications been obtained, where required?

Completing these checks before submission can help reduce regulatory queries and support a more efficient review process.

Avoidable Mistakes vs. Strategic Fixes

Many registration delays result from avoidable documentation issues rather than deficiencies with the device itself.

Final Thoughts: Optimizing the Dossier Review Cycle

Successfully navigating the documentation, dossier preparation, and electronic submission requirements for Indonesia requires a highly disciplined approach to regulatory data management. Most application delays on the Regalkes platform do not stem from fundamental product safety deficiencies, but rather from preventable clerical and administrative mismatches within the submission package itself.

Mitigating these regulatory risks demands strict internal consistency, ensuring that all product nomenclature, manufacturing site addresses, and translated terminology align seamlessly across both your administrative credentials and technical data sheets.

Ultimately, navigating this landscape requires local insight. Partnering with an experienced regulatory specialist helps you anticipate localized pitfalls, run rigorous pre-submission audits, and build a compliant bridge straight to Indonesian healthcare providers.

For specialized regulatory strategy, gap analysis, or direct submission support in Indonesia, contact Cisema today.

Further Information

• Explore Cisema’s services for medical device registration in Indonesia.
• Read Cisema’s guide to the complete medical device registration process in Indonesia.
• Learn more about Halal compliance for medical devices in in Indonesia.

References

• Ministry of Health Regulation No. 62 of 2017 on Medical Device Marketing Authorization
• Regalkes Indonesia Medical Device Registration System